Meeting
2023 ASCO Annual Meeting
Molecular landscape and survival outcomes on early phase clinical trials in sporadic young onset colorectal cancer.
Authors
Benny Johnson
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Benny Johnson , Jason Willis , Christopher Williams , Xuemei Wang , Grace L. Smith , Y. Nancy You , Ecaterina Elena Dumbrava , Siqing Fu , Daniel D. Karp , Aung Naing , Sarina A. Piha-Paul , Jordi Rodon Ahnert , Apostolia Maria Tsimberidou , Timothy A. Yap , Michael J. Overman , Shubham Pant , David S. Hong , Scott Kopetz , Funda Meric-Bernstam , Vivek Subbiah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3600)
DOI
10.1200/JCO.2023.41.16_suppl.3600
Abstract #
3600
Poster Bd #
300
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Colorectal cancer: Impact of primary tumor location on genetic alterations.
First Author: Mohamed E. Salem
Poster
2024 ASCO Gastrointestinal Cancers Symposium
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness.
First Author: Ramya Thota
First Author: Sandra Algaze
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Tumor mutations associated with outcomes in colorectal peritoneal metastases.
First Author: Abhineet Uppal